Stephanie Krebs
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Stephanie Krebs
The proxy statement of Faeth Therapeutics, Inc. reports total compensation of $730,701 for Stephanie Krebs in fiscal 2025, including a base salary of $346,420. Disclosed compensation is on record for 2 fiscal years.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Faeth Therapeutics, Inc. (FTH)
Proxy statement
Start not stated–2025-04-11
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Faeth Therapeutics, Inc. (FTH) | Former Chief Business Officer | $346,420 | $730,701 |
| 2024 | Faeth Therapeutics, Inc. (FTH) | Former Chief Business Officer | $385,000 | $584,386 |
Recent activity
No call appearances or filed executive changes recorded yet.